International Master/Ph.D. Program in Medicine

Organization profile

Organisation profile

The International Master/PhD Program in Medicine was established in 2016 and recruits international students from foreign countries such as Vietnam, Indonesia, Mongolia, Philippines, India, Gambia, United States and Japan. This graduate program was particularly designed for international students with expertise in clinical professional, biomedical research and healthcare related education. To accommodate individual aspiration, interests and career goals, IGPM designed more flexible study schemes and courses for students. These courses are categorized into four areas including (I) Molecular Medicine, (II) Clinical Research, (III) Prevention and Evidence-Based Medicine, and (IV) Medical Education (Master only). Furthermore, students are also allowed and encouraged to take English-taught courses from other disciplines in the TMU campus. For graduation, students either pursuing PhD or master degree should take and complete the required and elective courses with minimal total 30 credits including 18 credits from the required courses and 12 credits from the elective courses in PhD program, while 12 credits from the required courses and 18 credits from the elective courses in master program. In addition, students are absolutely required to submit and successful defense their thesis (for master) or dissertation (for PhD) to win degree and diploma.

IGPM provides the first-rate educational environment and ensure all future alumni are elite scholars or scientists, who can initiate research proposals, conduct and execute research projects independently and play the significant roles in their own professional fields. Furthermore, we expect IGPM alumni can bridge TMU to their homeland countries for strengthening international collaborations in medicine and biomedical research, leading to win-win situation for each participated institution.

Fingerprint Dive into the research topics where International Master/Ph.D. Program in Medicine is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

Taiwan Medicine & Life Sciences
Stroke Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Apoptosis Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Cells Chemical Compounds
Autophagy Medicine & Life Sciences
Proteins Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2016 2020


Lin, C.


Project: A - Government Institutionb - Ministry of Science and Technology

Research Output 2012 2020

Open Access

Mammalian target of rapamycin and p70S6K mediate thrombin-induced nuclear factor-κB activation and IL-8/CXCL8 release in human lung epithelial cells

Lin, C. H., Shih, C. H., Jiang, C. P., Wen, H. C., Cheng, W. H. & Chen, B. C., Feb 5 2020, In : European Journal of Pharmacology. 868, 172879.

Research output: Contribution to journalArticle

Complement Factor B

Protective effects of 10,11-dihydro-5H-dibenzo[b,f]azepine hydroxamates on vascular cognitive impairment

Kaur, N., Fang, Y. C., Lee, H. Y., Singh, A., Nepali, K., Lin, M. H., Yeh, T. K., Lai, M. J., Chan, L., Tu, Y. K., Banerjee, S., Hu, C. J. & Liou, J. P., Feb 1 2020, In : European Journal of Medicinal Chemistry. 187, 111915.

Research output: Contribution to journalArticle

Histone Deacetylase Inhibitors
Blood Vessels

Activities 2017 2017

  • 1 Oral presentation